.jpg?format=webp&quality=80&width=3840)
This study aimed to develop and validate an ultrasound (US)‐based radiomics score for pre‐biopsy prediction of prostate cancer (PCa) and subsequently reduce unnecessary PBs. The radiomics score consisted of five selected features. The radiomics score was an independent factor for pre‐biopsy prediction of PCa. The addition of the radiomics score to the clinical nomogram shows the incremental prognostic value and may help clinicians make precise decisions to reduce unnecessary PBs.
Like
Save
Share